Eyebright Medical Technology (Beijing) Co., Ltd.

SHSE:688050 Stock Report

Market Cap: CN¥15.0b

Eyebright Medical Technology (Beijing) Management

Management criteria checks 4/4

Eyebright Medical Technology (Beijing)'s CEO is Jiangbing Xie, appointed in Jun 2019, has a tenure of 5.25 years. directly owns 12.92% of the company’s shares, worth CN¥2.00B. The average tenure of the management team and the board of directors is 3.8 years and 4.9 years respectively.

Key information

Jiangbing Xie

Chief executive officer

CN¥1.3m

Total compensation

CEO salary percentagen/a
CEO tenure5.3yrs
CEO ownership12.9%
Management average tenure3.8yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

Eyebright Medical Technology (Beijing) Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Aug 23
Eyebright Medical Technology (Beijing) Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)

Jul 15
Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)

Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings

Jun 10
Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings

Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?

May 13
Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?

Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues

Apr 24
Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues

Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think

Apr 21
Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think

Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Mar 25
Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)

Mar 18
A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)

Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)

Mar 01
Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)

CEO

Jiangbing Xie (52 yo)

5.3yrs

Tenure

CN¥1,321,800

Compensation

Mr. Jiangbing Xie serves as Chairman of the Board and General Manager at Eyebright Medical Technology (Beijing) Co., Ltd. since June 2019 and is its Chief Scientist.


Leadership Team

NamePositionTenureCompensationOwnership
Jiangbing Xie
Chairman of the Board5.3yrsCN¥1.32m12.92%
CN¥ 1.9b
Baoshan Jia
Deputy GM & National Marketing Director5.3yrsCN¥1.61m0.0036%
CN¥ 540.0k
Zhao Wang
Deputy GM2.3yrsCN¥894.60k0.0042%
CN¥ 634.8k
Yuqian Zhou
Assistant to the GM & Board Secretary2.3yrsCN¥567.30k0.0064%
CN¥ 964.2k

3.8yrs

Average Tenure

44yo

Average Age

Experienced Management: 688050's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jiangbing Xie
Chairman of the Board5.3yrsCN¥1.32m12.92%
CN¥ 1.9b
Zhao Wang
Deputy GM4.5yrsCN¥894.60k0.0042%
CN¥ 634.8k
Fang Yu
Director5.3yrsno datano data
Haiyan Wang
Independent Director5.3yrsCN¥160.00kno data
Feng Jiang
Independent Director2.7yrsCN¥160.00kno data
Yu Jiao Wang
Employee Supervisor5.3yrsno datano data
Yong Chen
Director2.3yrsno datano data
Lin Liang
Supervisor2.3yrsno datano data

4.9yrs

Average Tenure

50yo

Average Age

Experienced Board: 688050's board of directors are considered experienced (4.9 years average tenure).